Cite
MLA Citation
Yihebali Chi et al.. “S-1/temozolomide versus S-1/temozolomide plus thalidomide in advanced pancreatic and non-pancreatic neuroendocrine tumours (STEM): A randomised, open-label, multicentre phase 2 trial.” EClinicalMedicine, vol. 54, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100172522069.0x000001